The Board of Directors has been authorized at the General Meeting of the Shareholders to grant restricted stock units (“RSU”), stock options plan (“SO”), and non-employee warrants (Bons de Souscription d’Actions or “BSA”).

During the three months ended June 30, 2025, the Company granted 215,000 stock options and 35,000 restricted stock units to one employee.

There have been no changes in the vesting conditions and method of valuation of the SO and RSUs from that disclosed in Note 12 to the consolidated financial statements included in the Annual Report.


	Number of outstanding
	BSA	SO	RSUs
Balance as of December 31, 2024	244,693	10,452,903	2,813,366
Granted during the period	—	215,000	35,000
Forfeited during the period	—	(66,100)	(82,850)
Exercised/released during the period	—	—	(36,192)
Expired during the period	(49,185)	(128,100)	—
Balance as of June 30, 2025	195,508	10,473,703	2,729,324

Share-based payments expense reflected in the condensed consolidated statements of operations is as follows:


		Three Months Ended June 30,		Six Months Ended June 30,
		2025	2024	2025	2024
Research & development	SO	(352)	(456)	(734)	(969)
	RSU	(191)	(241)	(390)	(497)
Sales & marketing	SO	(13)	(20)	(25)	(43)
	RSU	(6)	(9)	(12)	(18)
General & administrative	SO	(597)	(700)	(1,594)	(1,730)
	RSU	(86)	(100)	(192)	(226)
Total share-based compensation (expense)		(1,246)	(1,525)	(2,947)	(3,483)